Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 43, 2024 - Issue 1
158
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Lacrimal gland targeted therapies for refractory epiphora: quantitative changes in the gland activity

, &
Pages 74-79 | Received 24 Dec 2022, Accepted 14 Apr 2023, Published online: 01 May 2023

References

  • Singh S, Ali MJ, Paulsen F. A review on use of botulinum toxin for intractable lacrimal drainage disorders. Int Ophthalmol. 2018;38(5):2233–2238. doi:10.1007/s10792-017-0661-9.
  • Jeffers J, Lucarelli K, Akella S, Setabutr P, Wojno TH, Aakalu V. Lacrimal gland botulinum toxin injection for epiphora management. Orbit. 2022;41(2):150–161. doi:10.1080/01676830.2021.1966810.
  • Ziahosseini K, Al-Abbadi Z, Malhotra R. Botulinum toxin injection for the treatment of epiphora in lacrimal outflow obstruction. Eye (Lond). 2015;29(5):656–661. doi:10.1038/eye.2015.18.
  • Nava-Castã Neda A, Tovilla-Canales JL, Boullosa V, Tovilla-Y-Pomar JL, Monroy-Serrano MH, Tapia-Guerra V, et al. Duration of botulinum toxin effect in the treatment of crocodile tears. Ophthal Plast Reconstr Surg. 2006;22:453–456. doi:10.1097/01.iop.0000244515.07925.99.
  • Ahn C, Kang S, Sa HS. Repeated injections of botulinum toxin-A for epiphora in lacrimal drainage disorders: qualitative and quantitative assessment. Eye (Lond). 2019;33(6):995–999. doi:10.1038/s41433-019-0362-x.
  • Kaynak P, Karabulut GO, Ozturker C, Fazil K, Arat YO, Perente I, et al. Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction. Eye (Lond). 2016;30:1056–1062. doi:10.1038/eye.2016.88.
  • Murube J. History of dry eye. In: Lemp M Marquartdt R, eds. The Dry Eye: A Comprehensive Guide. Berlin: Springer-Verlag; 1992:3–34.
  • Scherz W, Dohlman CH. Is the lacrimal gland dispensable? Keratoconjunctivitis sicca after lacrimal gland removal. Arch Ophthalmol. 1975;93(4):281–283. doi:10.1001/archopht.1975.01010020291009.
  • Taiara C, Smith B. Palpebral dacryoadenectomy. Am J Ophthalmol. 1973;75(3):461–465. doi:10.1016/0002-9394(73)91156-2.
  • Hornblass A, Guberina C, Herschorn BJ. Palpebral dacryoadenectomy for epiphora. Ophthalmic Plast Reconstr Surg. 1988;4(4):227–230. doi:10.1097/00002341-198804040-00005.
  • Hornblass A, Mines JA. Transient visual loss following palpebral dacryoadenectomy and intraorbital hemorrhage. Ophthalmic Surg. 1982;13:815–818.
  • Singh S, Shanbhag SS, Basu S. Palpebral lobe of the human lacrimal gland: morphometric analysis in normal versus dry eyes. Br J Ophthalmol. 2021;105(10):1352–1357. doi:10.1136/bjophthalmol-2020-316929.
  • Singh S, Shanbhag SS, Basu S. Tear secretion from the lacrimal gland: variations in normal versus dry eyes. Br J Ophthalmol. 2022;106(6):772–776. doi:10.1136/bjophthalmol-2020-318159.
  • Trakos N, Singh S, Mishra DK, Ali MJ. Lacrimal gland botulinum toxin injection versus simple glandular needling: histopathological and electron microscopic evidence and potential clinical implications. Ophthalmic Plast Reconstr Surg. 2020;36(3):263–267. doi:10.1097/IOP.0000000000001528.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.